Condition
Portal Hypertension clinical trials and research
As of November 12, 2026, Find a Trial lists 37 Portal Hypertension clinical trials that are recruiting, at sites in 18 countries (most in China (12), Germany (6), Austria (4)). 1 was first registered in the last 30 days. By phase: Phase 4 (3), Phase 1/2 (1), Phase 3 (1). The most active sponsors are Medical University of Vienna (3), Chinese University of Hong Kong (3), Shanghai Zhongshan Hospital (3). There are also 8 NIH-funded research projects on Portal Hypertension, with $4.9 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 37Clinical trials
- 8NIH research projects
- 1New in 30 days
- 18Countries
Newest Portal Hypertension clinical trials
All recruiting trials (37)
-
Endohepatology-based reclassification of treatment indication in high-risk MASLD
This study tests whether an endohepatology assessment can change treatment decisions for adults with high-risk MASLD.
-
Coil-assisted small-diameter stent shunt reduction for refractory HE after TIPS
A coil-assisted, small-diameter covered-stent technique is being tested to see if it can safely and effectively reduce shunt flow and lessen recurrent hepatic encephalopathy in people with a prior TIPS.
-
Austrian PBC Registry
This registry follows adults with primary biliary cholangitis in Austrian centers to see how the disease develops over time and how biomarkers relate to complications and symptoms.
-
4D-Flow MRI to see portal hypertension and TIPS outcomes in cirrhosis
This study tests a noninvasive 4D-Flow MRI method to see if it can safely and reliably reflect portal hypertension and predict outcomes for people with cirrhosis, including those needing a TIPS procedure.
-
Apixaban plus carvedilol to prevent portal-hypertension complications in cirrhosis
This will test whether adding apixaban to carvedilol can help prevent variceal bleeding, portal vein thrombosis, and other portal-hypertension complications in adults with Child-Pugh B cirrhosis.
-
Blood clotting and portal vein changes during TIPS placement in cirrhosis
This project will see how blood clotting in the body and in the portal vein changes in adults with cirrhosis who are having a TIPS placed.
-
Comparing HVPG and endoscopic ultrasound portal pressure measurements
This study will test whether an endoscopic ultrasound method (EUS-PPG) gives the same portal pressure readings as the standard hepatic venous pressure gradient (HVPG) in adults who need portal pressure measurement.
-
Portal hypertension biobank for esophagogastric varices
This project will try to collect clinical data, CT images, and biological samples from people with portal hypertension and esophagogastric varices to support multi-omics studies and better-tailored care.
-
Portal hypertension with esophagogastric varices: endoscopic treatment vs. non-endoscopic care
This study tests whether endoscopic treatment helps people with portal hypertension and varices compared to those who don’t get endoscopic therapy.
-
Comparing terlipressin and somatostatin to lower portal pressure during living-donor liver transplant
This trial tests whether terlipressin or somatostatin better lowers portal pressure and reduces bleeding and transfusion needs in people having a right-lobe living-donor liver transplant.
-
Using TIPS to treat complicated portal hypertension in porto‑sinusoidal vascular disease
This research tries TIPS (a shunt placed in the liver) for people with porto‑sinusoidal vascular disease who have bleeding, refractory ascites, or portal vein thrombosis from portal hypertension.
-
Handgrip strength and portal vein blood flow in people with liver cirrhosis
This trial will test whether squeezing a handgrip changes portal vein and left gastric vein pressures and blood flow in adults with liver cirrhosis to see if muscle strength affects variceal hemodynamics.
-
Removing the spleen with open debridement for necrotizing pancreatitis and left-sided portal hypertension
This trial will test whether removing the spleen during open debridement helps adults with acute necrotizing pancreatitis and left-sided (sinistral) portal hypertension recover faster and with fewer complications than debridement alone.
-
Improving treatment strategies for bleeding from esophageal varices in portal hypertension
This study is trying to find better ways to treat bleeding from swollen veins in the esophagus for people with portal hypertension by personalizing treatment based on their specific conditions.
-
EUS-guided portal pressure measurement as an alternative to hepatic venous pressure
This trial will test whether an endoscopic ultrasound-guided portal pressure measurement (EUS-PPG) gives the same portal pressure readings as the standard HVPG in adults with portal hypertension from chronic liver disease.
-
Using advanced ultrasound techniques to detect portal hypertension
This study is testing a new ultrasound method to see if it can safely and accurately find portal hypertension in patients without needing invasive procedures.
-
Early TIPS for patients with liver cirrhosis and ascites
This study is testing if a procedure called TIPS can help people with liver cirrhosis and fluid buildup in their abdomen feel better compared to standard treatments like medications and draining the fluid.
-
Stopping non-selective beta-blockers in people with cirrhosis whose main cause is controlled
This study will try stopping non-selective beta-blockers in adults with cirrhosis who have their primary liver disease controlled, low liver stiffness, and no varices to see if varices come back within one year.
-
Using carvedilol to prevent liver complications in patients with advanced chronic liver disease
This study is testing if the medication carvedilol can help prevent serious liver problems in people with advanced chronic liver disease and high blood pressure in the liver.
-
Gathering data on hepatomiR for liver disease outcomes
This study is trying to see how a new test for liver disease can help doctors understand and predict serious problems in patients with chronic liver issues.
-
Noninvasive Prediction of Portal Hypertension in Cirrhosis Using STVi
This study tests whether the liver STVi ultrasound measurement can noninvasively predict clinically significant portal hypertension in adults with cirrhosis.
-
Measuring portal pressure in patients with advanced liver disease using endoscopic ultrasound
This study is testing if a new way of measuring pressure in the liver using endoscopic ultrasound is better than the traditional method for people with advanced liver disease and high blood pressure in the portal vein.
-
Using Ga-PSMA PET/MRI to assess liver cirrhosis
This study is testing a new imaging method to see if it can help doctors better understand liver function and damage in people with liver cirrhosis.
-
Non-invasive method to estimate portal and hepatic vein pressure
This study is testing a new, non-invasive MRI method to see if it can accurately measure blood pressure in the liver for people with serious liver disease.
-
Using spleen stiffness measurement to predict outcomes in liver disease patients with acute liver injury
This study is testing if measuring spleen stiffness can help predict how patients with chronic liver disease and acute liver injury will do in the short term.
-
Follow-up on the Lifetech Cera Vascular Plug System
This study is looking to see how well the Lifetech Cera Vascular Plug System works and if it’s safe for people who need treatment for blood vessel issues.
-
Registry for patients undergoing TIPS implantation for portal hypertension
This study is collecting information from patients with serious portal hypertension who are getting a TIPS procedure to see how well it works and what complications might happen afterward.
-
Assessing muscle loss and liver health in patients with advanced liver disease
This study is testing how muscle loss affects liver health in people with advanced liver disease by looking at their body composition and overall well-being over two years.
-
Using 3D-MRE to assess liver disease and portal hypertension
This study is testing if a new type of imaging called 3D-MRE can help doctors better understand and manage portal hypertension in patients with cirrhosis and advanced liver disease.
-
Noninvasive method to estimate portal hypertension using ultrasound
This study is testing a new ultrasound method to see if it can accurately measure pressure in the liver for people with liver diseases and portal hypertension.
-
Surgery to improve liver function in cirrhosis patients
This study tests whether a specific surgery can help improve liver function in patients with cirrhosis who have an enlarged spleen.
-
EUS-guided measurement of portal pressure gradient
This study will test an endoscopic ultrasound (EUS) technique to directly measure portal pressure in people with cirrhosis to see if it can safely and accurately indicate portal hypertension.
-
Predicting liver failure after surgery in patients with chronic liver disease
This study is trying to find out what causes liver failure after surgery in people with chronic liver disease to help doctors better predict risks for their patients.
-
Non-invasive evaluation for patients with portal hypertension receiving TIPS
This study is testing new ways to monitor patients with portal hypertension who are getting a TIPS procedure to see how well they do afterward.
-
Preventing liver complications after TIPS placement with rifaximin and lactulose
This study is testing if taking rifaximin and lactulose can help prevent brain problems in adults with liver cirrhosis after they have a procedure called TIPS.
-
Registry for patients with portal hypertension undergoing TIPS
This study is looking at patients with serious liver disease who have had a specific procedure called TIPS to see how they do afterwards and if certain markers can help predict any problems.
-
Observational study on advanced chronic liver diseases in Vienna
This study looks at patients with advanced chronic liver diseases in Vienna to see how their condition affects blood pressure in the liver and to collect samples for future research.
NIH-funded research (8)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Noninvasive portal pressure estimation using ultrasound-based subharmonic signals
A noninvasive ultrasound method to estimate portal vein pressure in adults with cirrhosis to help manage varices and ascites.
-
Noninvasive MRI test to measure liver and portal blood pressure
An advanced MRI technique to measure pressure in the liver and portal circulation for people with chronic liver disease or cirrhosis.
-
How molecular changes in the liver cause portal hypertension
This project looks at how changes in proteins that control nitric oxide in liver blood vessel cells lead to portal hypertension in people with liver injury.
-
Under-the-skin medicine for fluid buildup (ascites) from portal hypertension
A new injectable medicine given under the skin to help people with cirrhosis who have hard-to-treat fluid buildup in the belly.
-
Noninvasive method to measure portal vein pressure in cirrhosis
A noninvasive ultrasound technique called SHAPE could measure portal vein pressure in people with cirrhosis to help manage complications like variceal bleeding and ascites.
-
Noninvasive evaluation of liver pressure and health using advanced imaging techniques
This study is testing a new, painless way to check liver health and pressure using advanced imaging technology, which could help people with chronic liver disease get better and safer care without needing invasive procedures.
-
Understanding how liver injury affects blood flow in portal hypertension
This study is looking into how liver damage affects blood flow in people with portal hypertension, focusing on certain proteins that help control blood flow, so we can better understand the condition and find new ways to treat it.
-
Understanding how immune cells affect high blood pressure in the liver
This study is looking at how certain immune cells in the liver might be causing high blood pressure in the portal vein, which can happen in people with chronic liver disease, and it hopes to find new ways to help lower that pressure and improve treatment options for patients.
Related topics
Quick answers
How many Portal Hypertension clinical trials are recruiting right now?
37, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 18 countries. The most sites are in China (12 trials), Germany (6 trials), Austria (4 trials), United States (3 trials), France (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 3, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.